Mrk 590 was originally classified as a Seyfert 1 galaxy, but then it underwent dramatic changes: the nuclear luminosity dropped by over two orders of magnitude and the broad emission lines all but disappeared from the optical spectrum.Here we present followup observations to the original discovery and characterization of this "changing look" active galactic nucleus (AGN). The new Chandra and HST observations from 2014 show that Mrk 590 is awakening, changing its appearance again. While the source continues to be in a low state, its soft excess has re-emerged, though not to the previous level. The UV continuum is brighter by more than a factor of two and the broad Mg ii emission line is present, indicating that the ionizing continuum is also brightening. These observations suggest
We perform a spectral analysis of a sample of 11 medium redshift (1.5 z 2.2) quasars. Our sample all have optical spectra from the SDSS, infrared spectra from GNIRS and TSPEC, and X-ray spectra from XMM-Newton. We first analyse the Balmer broad emission line profiles which are shifted into the IR spectra to constrain black hole masses. Then we fit an energy-conserving, three component accretion model of the broadband spectral energy distribution (SED) to our multiwavelength data. Five out of the 11 quasars show evidence of an SED peak, allowing us to constrain their bolometric luminosity from these models and estimate their mass accretion rates. Based on our limited sample, we suggest that estimating bolometric luminosities from L 5100 Å and L 2−10 keV may be unreliable, as has been also noted for a low-redshift, X-ray selected AGN sample.
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-pro t purposes provided that:• a full bibliographic reference is made to the original source • a link is made to the metadata record in DRO • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders.Please consult the full DRO policy for further details.
We analyse four extreme active galactic nuclei (AGN) transients to explore the possibility that they are caused by rare, high-amplitude microlensing events. These previously unknown type-I AGN are located in the redshift range 0.6-1.1 and show changes of > 1.5 mag in the g band on a time-scale of ∼years. Multi-epoch optical spectroscopy, from the William Herschel Telescope, shows clear differential variability in the broad line fluxes with respect to the continuum changes and also evolution in the line profiles. In two cases, a simple point-source, point-lens microlensing model provides an excellent match to the long-term variability seen in these objects. For both models, the parameter constraints are consistent with the microlensing being due to an intervening stellar mass object but as yet there is no confirmation of the presence of an intervening galaxy. The models predict a peak amplification of 10.3/13.5 and an Einstein time-scale of 7.5/10.8 yr, respectively. In one case, the data also allow constraints on the size of the C iii] emitting region, with some simplifying assumptions, to be ∼ 1.0-6.5 light-days and a lower limit on the size of the Mg ii emitting region to be > 9 light-days (half-light radii). This C iii] radius is perhaps surprisingly small. In the remaining two objects, there is spectroscopic evidence for an intervening absorber but the extra structure seen in the light curves requires a more complex lensing scenario to adequately explain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.